These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11144504)

  • 1. Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor.
    Takagi Y; Takashi M; Koshikawa T; Sakata T; Ohshima S
    Int J Urol; 2000 Oct; 7(10):366-72. PubMed ID: 11144504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.
    Khan AA; Abel PD; Chaudhary KS; Gulzar Z; Stamp GW; Lalani EN
    Mol Pathol; 2003 Dec; 56(6):353-61. PubMed ID: 14645699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.
    Shin KY; Kong G; Kim WS; Lee TY; Woo YN; Lee JD
    Br J Cancer; 1997; 75(12):1788-92. PubMed ID: 9192983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group.
    Liukkonen T; Lipponen P; Raitanen M; Kaasinen E; Ala-Opas M; Rajala P; Kosma VM
    Urol Res; 2000 Oct; 28(5):285-92. PubMed ID: 11127704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression.
    Yang CC; Chu KC; Chen HY; Chen WC
    Urol Int; 2002; 69(3):190-4. PubMed ID: 12372886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer.
    Wagner U; Süess K; Luginbühl T; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Jordan P; Moch H; Mihatsch MJ; Gasser TC; Sauter G
    J Pathol; 1999 May; 188(1):44-50. PubMed ID: 10398139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
    Casetta G; Cavallini A; Piana P; Squintone L; Vottero M; Tizzani A
    Minerva Urol Nefrol; 1992; 44(3):169-72. PubMed ID: 1492266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
    Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
    Byrne RR; Shariat SF; Brown R; Kattan MW; Morton RA JR; Wheeler TM; Lerner SP
    J Urol; 2001 May; 165(5):1473-9. PubMed ID: 11342899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value.
    Lipponen P; Aaltomaa S; Eskelinen M; Ala-Opas M; Kosma VM
    Eur Urol; 1998 Sep; 34(3):237-43. PubMed ID: 9732201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder.
    Naruse K; Yamada Y; Nakamura K; Aoki S; Taki T; Zennami K; Katsuda R; Watanabe M; Nishikawa G; Itoh Y; Mitsui K; Hibi H; Honda N
    Oncol Rep; 2010 Jun; 23(6):1577-83. PubMed ID: 20428812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome.
    Sgambato A; Migaldi M; Faraglia B; De Aloysio G; Ferrari P; Ardito R; De Gaetani C; Capelli G; Cittadini A; Trentini GP
    Int J Cancer; 2002 Feb; 97(5):671-8. PubMed ID: 11807796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
    Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer.
    Patry G; Hovington H; Larue H; Harel F; Fradet Y; Lacombe L
    Int J Cancer; 2008 Apr; 122(7):1592-7. PubMed ID: 18058798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 expression is useful as a prognostic indicator for advanced esophageal carcinomas, but not for superficial tumors.
    Toyoda H; Nakamura T; Shinoda M; Suzuki T; Hatooka S; Kobayashi S; Ohashi K; Seto M; Shiku H; Nakamura S
    Dig Dis Sci; 2000 May; 45(5):864-9. PubMed ID: 10795746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features.
    Lee CC; Yamamoto S; Morimura K; Wanibuchi H; Nishisaka N; Ikemoto S; Nakatani T; Wada S; Kishimoto T; Fukushima S
    Cancer; 1997 Feb; 79(4):780-9. PubMed ID: 9024716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.